Medico Remedies Limited (MEDICO) - Total Liabilities

Latest as of March 2026: Rs779.29 Million INR ≈ $8.43 Million USD

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has total liabilities worth Rs779.29 Million INR (≈ $8.43 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medico Remedies Limited (MEDICO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Medico Remedies Limited - Total Liabilities Trend (2013–2026)

This chart illustrates how Medico Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medico Remedies Limited asset portfolio.

Medico Remedies Limited Competitors by Total Liabilities

The table below lists competitors of Medico Remedies Limited ranked by their total liabilities.

Company Country Total Liabilities
NPD Co. Ltd
KQ:198080
Korea ₩88.21 Billion
Century Lithium Corp.
V:LCE
Canada CA$184.90K
Maquia Capital Acquisition Corp
NASDAQ:MAQC
USA $9.56 Million
Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS
India Rs1.45 Billion
ORTOMA AB B
F:82Y
Germany €18.63 Million
Jeil Steel Mfg Co. Ltd
KQ:023440
Korea ₩60.19 Billion
Dusk Group Ltd
AU:DSK
Australia AU$54.92 Million
TDb Split Corp
TO:XTD
Canada CA$47.56 Million

Liability Composition Analysis (2013–2026)

This chart breaks down Medico Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Medico Remedies Limited's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.66 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.03 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medico Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medico Remedies Limited (2013–2026)

The table below shows the annual total liabilities of Medico Remedies Limited from 2013 to 2026.

Year Total Liabilities Change
2026-03-31 Rs779.29 Million
≈ $8.43 Million
+35.93%
2025-03-31 Rs573.30 Million
≈ $6.20 Million
+30.82%
2024-03-31 Rs438.24 Million
≈ $4.74 Million
+0.50%
2023-03-31 Rs436.05 Million
≈ $4.72 Million
+12.18%
2022-03-31 Rs388.70 Million
≈ $4.20 Million
-9.95%
2021-03-31 Rs431.63 Million
≈ $4.67 Million
-4.93%
2020-03-31 Rs454.03 Million
≈ $4.91 Million
-5.55%
2019-03-31 Rs480.74 Million
≈ $5.20 Million
+46.93%
2018-03-31 Rs327.20 Million
≈ $3.54 Million
+2.65%
2017-03-31 Rs318.74 Million
≈ $3.45 Million
+3.49%
2016-03-31 Rs307.99 Million
≈ $3.33 Million
+39.17%
2015-03-31 Rs221.30 Million
≈ $2.39 Million
-2.37%
2014-03-31 Rs226.68 Million
≈ $2.45 Million
+70.82%
2013-03-31 Rs132.70 Million
≈ $1.44 Million
--

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$31.31 Million
Rs2.90 Billion INR
Market Cap Rank
#23717 Global
#1309 in India
Share Price
Rs34.89
Change (1 day)
-3.99%
52-Week Range
Rs32.76 - Rs54.24
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more